Scottsdale, AZ – October 25, 2019 – Systems Imagination, the technology division of Systems Oncology, was highlighted as a top Microsoft client that uses big data to discover new tiers of medical insights unobtainable through conventional means. In the following featured article and video, Dr. Chris Yoo, CEO of Systems Imagination, explained how cutting-edge methodology helps process mass amount of biomedical data, and how the hypergraph his team has built plays a critical role in discovering new relationships between genes that unlocks hidden insights of cancers.
Systems Imagination- Answering Big Questions with Big Data
About Systems Oncology
Systems Oncology (SO) combines multi-scalar systems modeling with machine learning and big-data to uncover breakthrough insights into cancer biology and expose new therapeutic vulnerabilities. These discoveries are then used to better develop truly novel therapeutic agents. SO has the experience and knowhow needed to intelligently translate scientific insights into smarter clinical development strategies and faster registration paths. It then partners with leading pharmaceutical companies to accelerate the development of breakthrough cancer treatments. Fundamental to the SO approach is a next-generation AI platform for translating scientific insights into innovative cancer therapies with unprecedented speed, scale, and precision.